Page last updated: 2024-11-06

quinacainol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Quinacainol is a synthetic analog of quinacrine, a well-known antimalarial drug. It exhibits potent anti-inflammatory and anti-proliferative activities, making it a promising candidate for the treatment of various diseases, including inflammatory bowel disease, cancer, and autoimmune disorders. Quinacainol is synthesized through a multi-step process involving the modification of the quinacrine molecule. Its mechanism of action involves the inhibition of the NF-κB signaling pathway, a key regulator of inflammation and cell proliferation. Extensive research is ongoing to further investigate its therapeutic potential and optimize its pharmacological properties for clinical applications.'

quinacainol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID55464
CHEMBL ID2107029
SCHEMBL ID1815377
MeSH IDM0114404

Synonyms (27)

Synonym
quinacainol
pk-10139
quinacainolum
1-(2-tert-butylquinolin-4-yl)-3-piperidin-4-ylpropan-1-ol
1-(4-(2-tert-butylquinolyl))-3-(4-piperidyl)propanol
86073-85-0
pk 10139
rp 54272
4-quinolinemethanol, 2-(1,1-dimethylethyl)-alpha-(2-(4-piperidinyl)ethyl)-
(+-)-2-tert-butyl-alpha-(2-(4-piperidyl)ethyl)-4-chinolinmethanol
quinacainol [inn]
(+-)-2-tert-butyl-alpha-(2-(4-piperidyl)ethyl)-4-quinolinemethanol
unii-5ox8977ngo
5ox8977ngo ,
86024-64-8
CHEMBL2107029
4-quinolinemethanol, 2-(1,1-dimethylethyl)-.alpha.-(2-(4-piperidinyl)ethyl)-
(+/-)-2-tert-butyl-.alpha.-(2-(4-piperidyl)ethyl)-4-quinolinemethanol
OPNPUTUBENWDBA-UHFFFAOYSA-N
1-[2-(1,1-dimethyl-ethyl)-4-quinolyl]-3-(4-piperidyl)-1-propanol
SCHEMBL1815377
1-(2-(tert-butyl)quinolin-4-yl)-3-(piperidin-4-yl)propan-1-ol
pk 10139;pk 10139;pk 10139
Q27262668
DTXSID60868946
2-tert-butyl-alpha-(2-(4-piperidyl)ethyl)-4-chinolinmethanol
AKOS040747326
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]